Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVIX
2401
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
| $1.69M | ﹤0.01% |
+32,900
| New | +$2.82M |
|
|
NIU
2402
Niu Technologies
NIU
$203M
| $1.69M | ﹤0.01% |
197,717
+118,367
| +149% | +$1.06M |
|
2403
Quad
QUAD
$536M
| $1.69M | ﹤0.01% |
361,000
+101,000
| +39% | +$631K |
|
2404
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $1.69M | ﹤0.01% |
+10,300
| New | +$1.61M |
|
2405
Oil States International
OIS
$489M
| $1.68M | ﹤0.01% |
103,000
-38,900
| -27% | -$591K |
|
2406
Fastenal
FAST
$54.7B
| $1.68M | ﹤0.01% |
90,776
-233,600
| -72% | -$4.18M |
|
|
GPL
2407
DELISTED
Great Panther Mining Limited
GPL
| $1.67M | ﹤0.01% |
327,697
+44,871
| +16% | +$237K |
|
2408
Colony Bankcorp
CBAN
$465M
| $1.67M | ﹤0.01% |
101,119
-2,692
| -3% | -$42.5K |
|
2409
Werner Enterprises
WERN
$2.24B
| $1.66M | ﹤0.01% |
45,663
-13,500
| -23% | -$494K |
|
|
HARP
2410
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.66M | ﹤0.01% |
11,190
+8,450
| +308% | +$1.28M |
|
2411
Princeton Bancorp
BPRN
$281M
| $1.65M | ﹤0.01% |
52,523
+3,700
| +8% | +$109K |
|
2412
Digital Turbine
APPS
$975M
| $1.65M | ﹤0.01% |
230,964
+70,064
| +44% | +$521K |
|
|
SIOX
2413
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.64M | ﹤0.01% |
320,423
+42,400
| +15% | +$235K |
|
2414
Tetra Tech
TTEK
$8.49B
| $1.64M | ﹤0.01% |
+95,100
| New | +$1.65M |
|
2415
Harvard Bioscience
HBIO
$27.5M
| $1.64M | ﹤0.01% |
53,600
+2,079
| +4% | +$59.8K |
|
2416
Cytokinetics
CYTK
$10.5B
| $1.63M | ﹤0.01% |
153,767
+83,467
| +119% | +$857K |
|
2417
abrdn Physical Palladium Shares ETF
PALL
$618M
| $1.63M | ﹤0.01% |
44,500
+20,500
| +85% | +$695K |
|
2418
Vanguard S&P 500 ETF
VOO
$979B
| $1.63M | ﹤0.01% |
+5,500
| New | +$1.56M |
|
2419
Purple Innovation
PRPL
$35.3M
| $1.63M | ﹤0.01% |
7,468
+4,556
| +156% | +$878K |
|
2420
SIGA Technologies
SIGA
$235M
| $1.62M | ﹤0.01% |
338,818
+127,218
| +60% | +$648K |
|
2421
Matsons
MATX
$6.13B
| $1.61M | ﹤0.01% |
39,500
+33,200
| +527% | +$1.27M |
|
|
MFGP
2422
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.61M | ﹤0.01% |
+114,790
| New | +$1.59M |
|
2423
Chicago Rivet & Machine Co
CVR
$10M
| $1.61M | ﹤0.01% |
62,410
-1,400
| -2% | -$36.8K |
|
|
AAWW
2424
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.61M | ﹤0.01% |
58,400
+24,100
| +70% | +$602K |
|
2425
ProShares UltraPro Dow 30
UDOW
$841M
| $1.6M | ﹤0.01% |
+51,600
| New | +$1.45M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.